COVID-19 treatment

April 29, 2020

Vanderbilt investigators encouraged by early results of placebo-controlled remdesivir trial

A preliminary look at data from hospitalized adults diagnosed with coronavirus disease 2019 (COVID-19) in a randomized, controlled clinical trial to evaluate the safety and efficacy of the investigational antiviral remdesivir is showing promising results.

By Craig Boerner
April 28, 2020

Expanding clinical services at VUMC in a manner consistent with the roadmap to reopen Nashville

Consistent with the city’s Roadmap to Reopen Nashville, VUMC will reinitiate elective clinical services in a phased manner that prioritizes safety for patients and employees on Friday, May 1.

By VUMC News and Communications
April 23, 2020

VUMC joins global effort to explore COVID-19 genetics

Vanderbilt University Medical Center investigators have joined an international genetics effort to make advances as quickly as possible on understanding and treating COVID-19.

By Leigh MacMillan
April 17, 2020

Dr. Jeff Balser on flattening the curve and remaining prepared

Let me start by expressing my gratitude for the way you have supported one another and have risen to the challenge posed by Covid-19. Your courage, flexibility and hard work are having a tremendous impact. 
April 14, 2020

VUMC seeks plasma donations from recovered COVID-19 patients

Vanderbilt University Medical Center is recruiting volunteers who have tested positive for COVID-19 and fully recovered to donate plasma to help those who are currently ill with the virus as part of a new research study.

By VUMC News and Communications
April 9, 2020

My daughter had surgery at Children’s Hospital during the COVID-19 changes. Here’s what was different — and what was, thankfully, the same.

Temperature checks and social distancing were very different. The care and concern had not changed at all.

By Jessica Pasley
April 8, 2020

VUMC explores strategy to protect Emergency Department providers during COVID-19 pandemic

Policy changes related to telemedicine that were quickly implemented during the novel coronavirus pandemic (COVID-19) have created opportunities for technology-based clinical evaluation, which serves to protect patients and providers alike, while conserving personal protective equipment (PPE).
By Kathy Whitney
April 8, 2020

Vanderbilt University Medical Center and AstraZeneca join forces to identify potential COVID-19 treatments

Vanderbilt University Medical Center and the global biopharmaceutical company AstraZeneca have joined forces to identify candidates for antibody-based treatments that could protect people exposed to the 2019 novel coronavirus disease, COVID-19.
By Bill Snyder
April 8, 2020

Study launched to test hydroxychloroquine as treatment for COVID-19

By Craig Boerner
April 7, 2020

Frequent hand-washing can cause dry, cracked skin. A dermatologist offers tips for care.

The cure for "COVID hands" lies in frequent moisturizing. Using shortening from the kitchen is optional.
By VUMC News and Communications
April 6, 2020

VUMC team aids development of potential antiviral drug for COVID-19

Researchers at Vanderbilt University Medical Center are playing a key role in the development of a potential new antiviral drug to treat COVID-19.
By Bill Snyder
April 2, 2020

Dolly Parton makes generous gift to advance COVID-19 research at Vanderbilt

Legendary country music singer-songwriter Dolly Parton has made a generous gift to Vanderbilt University Medical Center that will increase scientific knowledge and advance the battle against COVID-19.
By VUMC News and Communications
April 2, 2020

Study aims to shield health workers from COVID-19 infection

VUMC is playing a key role in a national effort to establish a registry of U.S. health care workers and test whether the anti-malarial drug hydroxychloroquine (HCQ) will protect them, their patients and their families from COVID-19.
By Bill Snyder
1 … 9 10 11 12